Fundraising Fox

Theradaptive

Frederick, US · Delaware corporation · 2 known investors

theradaptive.com ↗

Theradaptive develops engineered protein therapeutics with improved targeted delivery to enhance efficacy and reduce side effects across clinical indications including orthopedics, soft tissue repair, and targeted chemotherapy. The company creates material binding variants of recombinant proteins to address delivery limitations in treating tissue loss conditions.

BiotechDeep TechMedical Devicesin /theradaptive

Founders & leadership

LA
Luis AlvarezExecutive Officer, Director
DS
David StewartExecutive Officer, Director
TA
Ted A. MeyersDirector
GS
George ShanineDirector
DH
David HarringtonDirector
JD
Jeffrey DunnDirector
PZ
Patrick ZhangDirector

Investors · 2

Horizons VenturesHong Kong · $1M – $110M
Maryland TEDCOUpper Marlboro · $500K – $1.5M

Competitors · 9

by search overlap
Adaptive Biotechnologies18 shared keywordsAdaptive Biotechnologies decodes the genetic patterns of the adaptive immune system to develop clinical products for diagnosing and treating disease. It applies immune-sequencing technology across a range of diseases to support diagnosis and treatment.
Diabetes Prevention Program15 shared keywords
Stanford blockchain12 shared keywords
Dervan et al11 shared keywords
Cowles_Investments_StemCentrx10 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.
ResearchGate10 shared keywords
BBB10 shared keywords
Ziprecruiter9 shared keywords
Built In9 shared keywords

Companies competing with Theradaptive for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
▶$36.2MraisedAug 2026 · 65 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luis AlvarezExecutive Officer, Director
  • David StewartExecutive Officer, Director
  • Ted A. MeyersDirector
  • George ShanineDirector
  • Patrick ZhangDirector
  • David HarringtonDirector
  • Jeffrey DunnDirector
Offering amount
$77.9M
Amount sold
$36.2M
First sale
Jul 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of DefenseDefense Health ProgramPhase II2020$1.1M
Department of DefenseDefense Health ProgramPhase I2017$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news